PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aidMary Ann Liebert, Inc.Mary Ann Liebert, Inc.JournalsSearchAlerts
AIDS Research and Human Retroviruses
 
AIDS Res Hum Retroviruses. 2011 September; 27(9): 1013–1017.
PMCID: PMC3161105

The Role of Dynamin in HIV Type 1 Env-Mediated Cell–Cell Fusion

Abstract

HIV-1 envelope glycoproteins are the key viral proteins that mediate HIV-1 entry and cell–cell fusion. In contrast to HIV-1 entry, the mechanism of HIV-1 Env-mediated cell–cell fusion is relatively unclear. This study demonstrated that dynasore, a dynamin inhibitor, suppressed HIV-1 Env-mediated cell–cell fusion. Dynasore sensitivity of HIV-1 Env-mediated cell–cell fusion varied depending on the viral strains. Results from testing a panel of gp41 cytoplasmic tail truncation mutants suggested that the gp41 cytoplasmic tail might play a role in dynasore sensitivity. HIV-1 Env-mediated cell–cell fusion could also be suppressed by a dynamin dominant-negative mutant DNM2(K44A). In summary, these results suggested that dynamin 2 might play a role in HIV-1 Env-mediated cell–cell fusion.

HIV-1 infection can result in fusion between susceptible CD4+ cells to form multinucleated syncytia. Similar to HIV-1 infection, syncytia formation involves the interaction between HIV-1 envelope glycoproteins and cellular receptor CD4 and chemokine receptors. It has been proposed that cell–cell fusion is a pathogenic mechanism that leads to CD4+ T cell depletion.13 In addition to its potential role in CD4 depletion, syncytia formation has also been implicated as an efficient mechanism of HIV-1 spread between infected and uninfected susceptible cells,4,5 although formation of virological synapses, nanotubes, and filopodial bridges might also mediate HIV-1 cell–cell spread.69

It is clear that HIV-1 gp120 and gp41 are the viral proteins that mediate both HIV-1 infection and HIV-1 Env-mediated cell–cell fusion. However, other than CD4 and chemokine receptors, cellular factors involved in the HIV-1 entry and HIV-1 Env-mediated cell–cell fusion remain to be further studied. The cellular protein dynamin 2 was implicated in HIV-1 entry through endocytosis.10 Dynamin 2 is a large cellular GTPase involved in the formation of endocytic vesicles through fission.11,12 It is interesting that dynamin could also mediate a seemingly reverse activity by being involved in membrane fusion.13,14 Although dynamin 2 was implicated in cell-free HIV-1 infection through endocytosis,10 it is not clear whether dynamin 2 might be involved in HIV-1 Env-mediated cell–cell fusion. Here, we used a cell–cell fusion model to show that dynamin 2 might play a role in HIV-1 Env-mediated cell–cell fusion.

To determine whether dynamin plays a role in HIV-1 Env-mediated cell–cell fusion, COS cells expressing HIV-1 Env from various HIV-1 strains were used to fuse with TZM-bl cells, a reporter cell line that expresses luciferase upon fusion15,16 in the presence of the dynamin GTPase inhibitor dynasore (Tocris Bioscience, Ellisville, MO). The HIV-1 sequence spanning env and tat genes were cloned into the expression vector pSHRS. The viral Envs used in this study were derived from the R5 viruses ADA, AC10.0.29, and YU-2; the X4 viruses NL4-3, HIV-1 8x, and Wtt; and the dual tropic virus DH012. ADA, NL4-3, and YU-2 were obtained from the NIH AIDS Research and Reference Reagent Program. AC10.0.29 (AC10) is a molecular clone derived from an R5 primary isolate.17 The DH012 Env used in this study contains gp120 from the dual tropic DH012 and gp41 from NL4-3.18 HIV-1 8x is an HIV-1 IIIB variant lacking the cytoplasmic tail of HIV-1 gp41, whereas Wtt is an HIV-1 8x revertant with the full gp41 cytoplasmic tail restored.1921 Electroporation was used to transfect COS cells with the expression vector pSRHS containing HIV-1 Env genes.16 COS cells (1×106 cells/ml) were transfected with HIV-1 Env-expressing vectors (0.5 μg) for 1 day before mixing with TZM-bl cells for fusion.

The sensitivities of the Env-mediated cell–cell fusions to dynasore varied among the tested HIV-1 Envs in the order of DH012>NL4-3=Wtt>YU-2>AC10.0.29>8x>ADA (Fig. 1a). The dynasore concentration required to inhibit DH012-Env mediated cell–cell fusion by 50% (IC50) is 34 μM, whereas the IC50 for HIV-1 ADA Env-mediated cell–cell fusion is >230 μM. As shown in Fig. 1b, the effect of dynasore on HIV-1 Env-mediated cell–cell fusion was not due to cytotoxicity. Under the experimental conditions, dynasore had minimal cytotoxicity against both COS and TZM-bl cells at 230 μM. The differential sensitivity of various HIV-1 Envs to dynasore suggested that dynamin played a role in HIV-1 envelope-mediated cell–cell fusion. The differential dynasore sensitivity also supported the notion that inhibition of the HIV-1 Env-mediated cell–cell fusion was not due to cytotoxicity.

FIG. 1.
Inhibition of HIV-1 Env-mediated cell–cell fusion by dynasore. (a) HIV-1 Env expressing COS cells were fused with TZM-bl cells for 24 h. Fusion of each Env in the presence of dynasore is defined as percent of fusion with dynasore/fusion ...

The IC50 of dynasore against Wtt-Env-mediated cell–cell fusion was approximately 57 μM, whereas the IC50 for the 8x-Env was greater than 230 μM (Fig. 1a). This differential sensitivity of Wtt and 8x to dynasore was not due to differential surface expression or the fusion efficiency of the Envs (Fig. 1b). The two Envs had similar fusion efficiency in the presence of low concentrations of dynasore. FACS analysis also indicated that the two envelopes had a similar level of surface expression (Fig. 1b, inset). The only difference between the two viruses is that 8x lacks the cytoplasmic tail of gp41. The differential sensitivities between Wtt and 8x to dynasore suggested that the cytoplasmic tail of HIV-1 gp41 might be a key determinant for the dynasore inhibitory activity. HIV-1 gp41 contains a long cytoplasmic tail (CT) of approximately 150 amino acids. The CT is highly conserved in length and sequence across diverse strains of HIV-1, suggesting functional significance for this region of the HIV Env. The CT contains an antibody-reactive putative beta turn region22,23 and three conserved alpha helical domains. The conserved alpha helical domains are also termed lentivirus lytic peptides (LLP).24,25

To determine the gp41 cytoplasmic motifs that are critical for dynasore sensitivity, a series of Wtt gp41 cytoplasmic tail truncation mutants were used in the Env-mediated cell–cell fusion assay (Table 1a). Wtt-Env mutants, Wtt.802, Wtt.769, and Wtt.723, remained quite sensitive to dynasore when most of the cytoplasmic tail was truncated from the C-terminus (Table 1b). In contrast, Wtt.707, Wtt.714, and Wtt.718, completely lacking or with a short cytoplasmic tail (0–12 amino acids), were much less sensitive to dynasore (Table 1b). It is interesting that Wtt.723 was at least 5-fold more sensitive to dynasore when compared to Wtt.718, even though the Env surface expression level of Wtt.723 and Wtt.718 was comparable (data not shown). Substitution of amino acids 719–723 of Wtt.723 with five alanines resulted in a construct, Wtt.7235A, that was much less sensitive to dynasore. In contrast to dynasore, the HIV-1 entry inhibitor IC9564 was equally potent against Wtt.723 and Wtt.718. IC9564 is a betulinic acid derivative that targets HIV-1 gp120.26 This result further supported the notion that there was a differential interaction between dynamin and the two HIV-1 Env variants, which might be responsible for their differential sensitivity to dynasore.

Table 1.
Differential Sensitivity of HIV-1 Wtt Variants to Dynasore

Endocytosis was implicated as a route for HIV-1 infection.10,2730 An endocytic motif YXXØ (amino acid residues 712–715) resides in the N-terminus of the gp41 cytoplasmic tail.3133 To determine whether the YXXØ motif affects dynasore sensitivity of HIV-1 Env-mediated cell–cell fusion, the YXXØ motif of Wtt.718 was mutated to GXXØ in Wtt .718(Y712G). The data in Table 1b show that knocking out the endocytic motif did not affect dynasore sensitivity.

To further determine the role of dynamin 2 in HIV-1 Env-mediated cell–cell fusion, a dominant negative dynamin 2 mutant, DNM2(K44A), was tested for its effect on HIV-1 Env-mediated cell–cell fusion. AC10.0.29, YU2, 8x, ADA, or DH012 Env expression vectors were cotransfected into COS cells with either wild-type dynamin 2, the dominant negative DNM2(K44A) mutant, or an empty expression vector as a control. Env expressing COS cells were mixed with TZM-bl cells and Env-mediated cell–cell fusion was measured at various time points. The dominant negative mutant DNM2(K44A) inhibited YU-2 and AC10 Env-mediated cell–cell fusions by more than 75%, 9 h after initiation of cell–cell fusion (Fig. 2). The inhibitory effect was not as strong at 24 h but fusion was still inhibited at this time point by approximately 50%. Similar to the lack of sensitivity to dynasore, ADA, and 8x Env-mediated cell–cell fusion were also resistant to DNM2(K44A). On the other hand, DH012 Env-mediated cell–cell fusion was very sensitive to dynasore inhibition when compared to YU-2 and AC10 (Fig. 1a). However, DH012 Env-mediated cell–cell fusions did not exhibit such a differential sensitivity to DNM2(K44A). The lack of correlation between dynasore and DNM2(K44A) sensitivity suggested that the mechanism of inhibition by the two dynamin inhibitors might not be the same.

FIG. 2.
Inhibition of HIV-1 Env-mediated cell–cell fusion by dynamin dominant negative mutant DNM2(K44A). Plasmids expressing dynamin 2 and a mutant, DNM2 and DNM2(K44A), were kindly provided by Drs. Pizzato and Göttlinger.38 DNM2, DNM2(K44A), ...

Dynamin 2 was implicated in HIV-1 virus entry by regulating the fusion between virus and endosome.10 Results from this study showed that Env from various HIV-1 strains including R5, X4, and dual-tropic viruses exhibited a range of sensitivity to dynasore. The fact that a greater than 5-fold difference in dynasore sensitivity between Wtt.723 and Wtt.718 suggests that the cytoplasmic tail of gp41 might be an important determinant for dynasore sensitivity.

Dynamin was linked to vacuole fusion mediated by SNARE. The SNARE proteins mediate membrane fusion through conformational changes and formation of helix bundles.34,35 This is reminiscent of HIV-1 gp41-mediated membrane fusion that involves both conformational changes and formation of 6-helix bundles. It is possible that there might be a direct or indirect interaction between dynamin 2 and gp41. However, it is not clear why some HIV-1 Env-mediated cell–cell fusion, such as that of ADA and 8x, are not sensitive to dynasore. One possible explanation for the lack of dynasore sensitivity is that these HIV-1 Envs might be able to mediate cell–cell fusion without dynamin. It is well documented that HIV-1 might enter susceptible cells through different mechanisms including transcytosis, endocytosis, and fusion of virus and cell membrane.36 Dynamin 2 was implicated in free HIV-1 entry through endocytosis. On the other hand, it is not clear whether dynamin 2 plays a role in the fusion of virus and cell membrane. Many viral and cellular factors, such as variation in Env sequence, level of receptor expression, or cell type, may affect the Env-mediated cell–cell fusion. Thus, it is possible that dynamin 2 is not required for ADA and 8x Env-mediated cell–cell fusion. In summary, the results of this study suggested that dynamin 2 might play a role in HIV-1 Env-mediated cell–cell fusion.37,38 By regulating HIV-1 Env-mediated cell–cell fusion, dynamin 2 might play a role in viral spread from infected cells to uninfected cells and HIV-1 pathogenesis.

Acknowledgments

This study was supported by the Collaboration for AIDS Vaccine Discovery (Bill and Melinda Gates Foundation) and by the U.S. National Institutes of Health (AI065310).

Author Disclosure Statement

No competing financial interests exist.

References

1. Ferri KF. Jacotot E. Blanco J, et al. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: Role of mitochondria and caspases. J Exp Med. 2000;192:1081–1092. [PMC free article] [PubMed]
2. Castedo M. Perfettini JL. Andreau K. Roumier T. Piacentini M. Kroemer G. Mitochondrial apoptosis induced by the HIV-1 envelope. Ann NY Acad Sci. 2003;1010:19–28. [PubMed]
3. Perfettini JL. Castedo M. Roumier T, et al. Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ. 2005;12(Suppl 1):916–923. [PubMed]
4. Gupta P. Balachandran R. Ho M. Enrico A. Rinaldo C. Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. J Virol. 1989;63:2361–2365. [PMC free article] [PubMed]
5. Sato H. Orenstein J. Dimitrov D. Martin M. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology. 1992;186:712–724. [PubMed]
6. Jolly C. Kashefi K. Hollinshead M. Sattentau QJ. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med. 2004;199:283–293. [PMC free article] [PubMed]
7. Chen P. Hubner W. Spinelli MA. Chen BK. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol. 2007;81:12582–12595. [PMC free article] [PubMed]
8. Sherer NM. Lehmann MJ. Jimenez-Soto LF. Horensavitz C. Pypaert M. Mothes W. Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat Cell Biol. 2007;9:310–315. [PMC free article] [PubMed]
9. Sowinski S. Jolly C. Berninghausen O, et al. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat Cell Biol. 2008;10:211–219. [PubMed]
10. Miyauchi K. Kim Y. Latinovic O. Morozov V. Melikyan GB. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell. 2009;137:433–444. [PMC free article] [PubMed]
11. Sweitzer SM. Hinshaw JE. Dynamin undergoes a GTP-dependent conformational change causing vesiculation. Cell. 1998;93:1021–1029. [PubMed]
12. Praefcke GJ. McMahon HT. The dynamin superfamily: Universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol. 2004;5:133–147. [PubMed]
13. Peters C. Baars TL. Buhler S. Mayer A. Mutual control of membrane fission and fusion proteins. Cell. 2004;119:667–678. [PubMed]
14. Peplowska K. Ungermann C. Expanding dynamin: From fission to fusion. Nat Cell Biol. 2005;7:103–104. [PubMed]
15. Wei X. Decker JM. Liu H, et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother. 2002;46:1896–1905. [PMC free article] [PubMed]
16. Huang L. Ho P. Lee KH. Chen CH. Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives. Bioorg Med Chem. 2006;14:2279–2289. [PubMed]
17. Montefiori DC. Altfeld M. Lee PK, et al. Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual. J Immunol. 2003;170:3906–3914. [PubMed]
18. Zhu CB. Zhu L. Holz-Smith S. Matthews TJ. Chen CH. The role of the third beta strand in gp120 conformation and neutralization sensitivity of the HIV-1 primary isolate DH012. Proc Natl Acad Sci USA. 2001;98:15227–15232. [PubMed]
19. LaBranche CC. Hoffman TL. Romano J, et al. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity. J Virol. 1999;73:10310–10319. [PMC free article] [PubMed]
20. Edwards TG. Hoffman TL. Baribaud F, et al. Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein. J Virol. 2001;75:5230–5239. [PMC free article] [PubMed]
21. Wyss S. Dimitrov AS. Baribaud F. Edwards TG. Blumenthal R. Hoxie JA. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J Virol. 2005;79:12231–12241. [PMC free article] [PubMed]
22. Chanh TC. Dreesman GR. Kanda P, et al. Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J. 1986;5:3065–3071. [PubMed]
23. Kennedy RC. Henkel RD. Pauletti D, et al. Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science. 1986;231:1556–1559. [PubMed]
24. Venable RM. Pastor RW. Brooks BR. Carson FW. Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein. AIDS Res Hum Retroviruses. 1989;5:7–22. [PubMed]
25. Eisenberg D. Wesson M. The most highly amphiphilic alpha-helices include two amino acid segments in human immunodeficiency virus glycoprotein 41. Biopolymers. 1990;29:171–177. [PubMed]
26. Lai W. Huang L. Ho P. Li ZJ. Montefiori D. Chen CH. Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of HIV-1. Antimicrob Agents Chemother. 2008;52:128–136. [PMC free article] [PubMed]
27. Pauza CD. Price TM. Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. J Cell Biol. 1988;107:959–968. [PMC free article] [PubMed]
28. Grewe C. Beck A. Gelderblom HR. HIV: early virus-cell interactions. J Acquir Immune Defic Syndr. 1990;3:965–974. [PubMed]
29. Bourinbaiar AS. Phillips DM. Transmission of human immunodeficiency virus from monocytes to epithelia. J Acquir Immune Defic Syndr. 1991;4:56–63. [PubMed]
30. Daecke J. Fackler OT. Dittmar MT. Kräusslich HG. Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J Virol. 2005;79:1581–1594. [PMC free article] [PubMed]
31. Rowell JF. Stanhope PE. Siliciano RF. Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. J Immunol. 1995;155:473–488. [PubMed]
32. Ohno H. Aguilar RC. Fournier MC. Hennecke S. Cosson P. Bonifacino JS. Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family. Virology. 1997;238:305–315. [PubMed]
33. Boge M. Wyss S. Bonifacino JS. Thali M. A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor. J Biol Chem. 1998;273:15773–15778. [PubMed]
34. Antonny B. SNARE filtering by dynamin. Cell. 2004;119:581–582. [PubMed]
35. Südhof TC. Rothman JE. Membrane fusion: Grappling with SNARE and SM proteins. Science. 2009;323:474–477. [PubMed]
36. Permanyer M. Ballana E. Esté JA. Endocytosis of HIV: Anything goes. Trends Microbiol. 2010;18:543–551. [PubMed]
37. Chen CH. Matthews TJ. Bolognesi DP. Greenberg ML. A molecular clasp in the HIV-1 TM protein determines the anti-HIV activity of gp41 derivatives: Implications for viral fusion. J Virol. 1995;69:3771–3777. [PMC free article] [PubMed]
38. Pizzato M. Helander A. Popova E, et al. Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. Proc Natl Acad Sci USA. 2007;104:6812–6817. [PubMed]

Articles from AIDS Research and Human Retroviruses are provided here courtesy of Mary Ann Liebert, Inc.